Eloxx Pharmaceuticals, Inc. ( ELOX) - Key Metrics
ELOX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.03 | -$1.09 | -$1.09 |
| 2026Q1 | $0 | -$0.86 | -$1.24 | -$1.24 |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q1 | $0 | -$4.94 | $3.48 | $3.48 |
| 2023Q3 | $0 | -$14.38 | -$13.81 | -$13.81 |
ELOX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.26 |
| 2026Q1 | 0% | -0.02 |
| 2025Q4 | ? | ? |
| 2025Q1 | 0% | 0.00 |
| 2023Q3 | 0% | -0.08 |
ELOX
Price: $12.80
52 week price:
Earnings Per Share: -8.88 USD
P/E Ratio: -0.10
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 67300
Market Capitalization: 53.3 million